Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Omeros stock skyrockets as narsoplimab improves survival in pivotal TA-TMA trial Omeros Corporation, a Seattle-based biopharmaceutical company, is making waves after releasing results from its pivotal clinical trial for… byPallavi MadhirajuDecember 19, 2024